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Abstract
Background: Neural stem cells (NSCs) can be isolated from the adult mammalian brain and
expanded in culture, in the form of cellular aggregates called neurospheres. Neurospheres provide
an in vitro model for studying NSC behaviour and give information on the factors and mechanisms
that govern their proliferation and differentiation. They are also a promising source for cell
replacement therapies of the central nervous system. Neurospheres are complex structures
consisting of several cell types of varying degrees of differentiation. One way of characterising
neurospheres is to analyse their gene expression profiles. The value of such studies is however
uncertain since they are heterogeneous structures and different populations of neurospheres may
vary significantly in their gene expression.
Results: To address this issue, we have used cDNA microarrays and a recently reported tag
cDNA amplification method to analyse the gene expression profiles of neurospheres originating
from separate isolations of the lateral ventricle wall of adult mice and passaged to varying degrees.
Separate isolations as well as consecutive passages yield a high variability in gene expression while
parallel cultures yield the lowest variability.
Conclusions:  We demonstrate a low technical amplification variability using the employed
amplification strategy and conclude that neurospheres from the same isolation and passage are
sufficiently similar to be used for comparative gene expression analysis.
Background
The most frequently used method to analyse scarce RNA
samples is to employ RNA amplification technology [1,2],
enabling analysis of the full length transcripts. We have
recently reported on an alternative transcriptome amplifi-
cation method that minimises differences in transcript
length in the amplification step [3,4]. This method is
based on fragmentation of the mRNA (cDNA) population
followed by isolation of a unique, short and representa-
tive 3'end tag of each transcript prior to amplification by
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PCR. Here we have evaluated and applied the methodol-
ogy on neural stem cells (NSCs).
NSCs can be isolated from the fetal or adult mammalian
brain and grown in vitro in the presence of growth factors
to form floating aggregates of cells denoted neurospheres
[5-7]. A neurosphere is derived from one clonally
expanded NSC or progenitor cell [8]. As the original NSC
or progenitor cell proliferates the new cells adhere to each
other, eventually forming a neurosphere. Every neural
stem cell in a neurosphere has the potential to differenti-
ate towards a neuronal or a glial lineage depending on the
internal neurosphere milieu and external signals. Neuro-
spheres are thus complex structures consisting of many
cell types that can have varying degrees of differentiation
commitment, but that are all derived from the same clon-
ally expanded cell. Neurospheres have extensive cell-cell
contacts and a dense extracellular matrix. When plated
onto solid support in combination with growth factor
withdrawal the cells start to differentiate into all neural
cell types (neurons, astrocytes and oligodendrocytes)[9].
In vitro expanded neural stem cells may therefore serve as
an  in vitro model of neurogenesis. The similarities
between the in vivo and in vitro processes of neurogenesis
are not well established although some characteristics are
expected to be conserved [10] and therefore challenging a
cell in vitro will unveil some of its developmental proper-
ties and potentials. By subjecting neurospheres to differ-
ent microenvironments (e.g. through the addition or
withdrawal of drugs or factors) it is possible to uncover
factors and mechanisms important for proliferation or
differentiation into certain cell lineages, for example neu-
rons of a particular type [11,12]. Furthermore, NSCs
expanded as neurospheres also hold the promise of
becoming an important source of cells for cell replace-
ment therapies of different neurological diseases [13,14].
Due to the great scientific interest in NSCs and the prom-
ise of their clinical use we decided to investigate NSCs
from a gene expression perspective. An important aspect
was to investigate if neurosphere heterogeneity [8] is
reflected in their transcriptome. Neurosphere populations
from different levels of technical and biological replica-
tion were analysed by taking advantage of microarrays
with 5159 spotted mouse cDNA clones, in combination
with a highly sensitive amplification method. We com-
pared neurospheres cultured under identical conditions
but in separate culture flasks, as well as from different pas-
sages and from parallel isolations. The results are dis-
cussed from the perspective of differences in the number
and extent of differentially expressed genes.
Results
Different sources of neurospheres were used to investigate
the extent of heterogeneity between neurosphere popula-
tions at the gene expression level. To facilitate a broad
transcript analysis of this relatively scarce material a
recently developed amplification methodology [3,4] was
used (Figure 1A) in combination with microarray technol-
ogy. In brief, the approach involves biotinylation of the
3'-end of the cDNA using a biotinylated oligo(dT) primer
in the first-strand cDNA synthesis reaction. The cDNA is
randomly fragmented by sonication into 50–500 bp frag-
ments. The 3'-ends (denoted 3'-end signature tags), repre-
senting the most unique part of most transcripts, are
isolated by binding to streptavidin-coated beads. Linkers
are ligated onto the 3'-end signature tags, which are sub-
sequently cleaved off the beads and finally amplified
using PCR. This generates a smear of random-sized frag-
ments (data not shown) which is labelled by asymmetric
PCR and then hybridised to microarrays. Here we used a
mouse microarray comprising of 5159 mouse cDNA
clones, printed in duplicate.
Differential expression was determined in a series of
microarray experiments, as outlined in Figure 1B. Neuro-
sphere cultures were initiated from cells dissociated from
three pools of adult lateral ventricle wall tissue dissected
from either 3 or 10 mice, as three identical but separate
isolations. Primary neurospheres were passaged one or
two times and harvested three to four days after passage.
Average neurosphere size was deemed a more critical fac-
tor than the length of the incubation time, hence some
neurosphere cultures were incubated for one day longer
than others to obtain uniformity in neurosphere size
between cultures at the key times of passaging and har-
vesting. When passaged twice the neurospheres were split
into two or three equivalent cultures. This allowed us to
measure the variability in gene expression levels between
different isolations, as well as between passages and
between parallel cultures. In order to estimate the techni-
cal noise, self-to-self hybridisations were performed using
RNA from one of the cultures. To confirm that we were
able to detect differential gene expression cells in one of
the parallel cultures were induced to differentiate into
neurons, astrocytes and oligodendrocytes by withdrawing
the growth factors from the culture medium, plating on
solid support and adding serum (in this work referred to
as differentiated cells). The nomenclature of the samples
is given in Figure 1B. Seven different comparisons were
made; A1-A2 (technical replicate), CI-CII and CII-CIII
(culture replicates), B-CI (different passages), A2-CIII and
CII-FI (different isolations) and F-G (neurospheres vs. dif-
ferentiated cells). The use of short-term passaged neuro-
spheres limits the number of cells that can be generated.
Consequently the amount of RNA that can be isolated is
below that normally used in labelling reactions for micro-
array hybridisations (approximately 10 µg total RNA
without amplification). After mRNA isolation and cDNA
synthesis we therefore chose to amplify the obtainedBMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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Experimental approach; A) Schematic overview of the utilised amplification protocol Figure 1
Experimental approach; A) Schematic overview of the utilised amplification protocol. For details see text. B) Experimental 
design. NSCs were isolated from the lateral ventricular region of brains from three pools of mice (three isolations) and grown 
as neurospheres. Sample G was induced to differentiate by withdrawing the growth factors from the culture medium, plating 
on solid support and adding serum. RNA was isolated from different passages as indicated and used for subsequent microarray 
hybridisations. Blue arrows represent duplicate hybridisations, arrowhead represents labelling with Cy5 and arrow tail repre-
sents labelling with Cy3.
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material using the method described above. Two replicate
and two dye-swap hybridisations were performed for each
comparison, adding up to four hybridisations for each
comparison in total.
The microarray data was filtered (for details see Methods)
and print-tip lowess normalised. Differentially expressed
genes were identified using an empirical Bayes moderated
t-test and by calculation of the associated p-values
[15,16]. In the t-test the contribution of within-array rep-
licate features was taken into account [17] and the genes
were ranked according to the probability of differential
expression (B-value; depending on both the fold change
and the variability over the four hybridisations). Higher B-
value indicates higher probability of differential expres-
sion. Genes were defined as differentially expressed if the
fdr-adjusted p-value was < 0.001 (corresponding to an
approximative B-value > 0.3). In Figure 2 the B-value dis-
tribution for each comparison is shown. The figure shows
no differentially expressed (DE) genes in the technical
replicate (using the amplification strategy), a higher
number of DE genes in neurospheres cultured in parallel,
an even higher number of DE genes in neurospheres from
different isolations and passages, and the highest number
of DE genes in neurospheres vs. differentiated cells. Note
the high number of DE genes in neurospheres from the
same isolation but subsequent passages (B-CI), indicating
that the neurospheres may change character over time as
they grow and proliferate in vitro.
To further investigate the variability in gene expression
between the different neurosphere samples we visualised
the data using a series of plots displayed in Figure 3. In
panel A) the average A-value (1/2log2(sample X intensity
* sample Y intensity)) for each gene is plotted against the
corresponding M-value (log2(sample X intensity / sample
Y intensity)). The plots show that after filtration and nor-
malisation there is no intensity bias in the distribution of
DE genes. They also show that the M-values for the tech-
nical replicates (A1-A2) are collected and centred close to
zero (corresponding to a ratio of 1), whereas the spread-
ing of the M-values are higher for culture replicates (CI-CII
and CII-CIII), passage replicates (B-CI) and isolation rep-
licates (A2-CIII and CII-F). The highest spreading of M-
values can be seen for the neurosphere vs. differentiated
cells hybridisations (F-G), where many genes have M-val-
ues between +/-1 and +/-3 (corresponding to a fold
change of 2 to 8). In panel B) the B-value for each gene is
plotted against the corresponding M-value. By definition
genes with a high M-value will obtain a higher B-value,
which gives the plots the characteristic volcano shape.
Also here it is clear that the technical replicates have no
statistically significant DE genes (with high B-values),
whereas culture, passage and isolation replicates have sev-
eral genes with high B-values, and the neurosphere vs. dif-
ferentiated cells comparison clearly has the highest
number of DE genes. This is further visualised in Figure 3,
panel C), where the average of the signal intensity for each
gene and sample is plotted against the average signal
intensity for that gene in the other sample. Once again the
Pearson correlation for the two samples is highest for the
technical replicates (r = 0.99), lower for the culture repli-
cates (r = 0.98 and r = 0.98 respectively), passage replicate
(r = 0.94) and isolation replicates (r = 0.95 and r = 0.96
respectively) and lowest for the neurosphere vs. differen-
tiated cells (r = 0.85).
The number of differentially expressed genes in each com-
parison is summarised in Figure 4. Genes with a false dis-
covery rate (fdr) adjusted p-value < 0.001, giving less than
one false positive per 1000 genes, are included. This fur-
ther demonstrates that the lowest number of DE genes is
in the technical replicates and the highest number in the
comparison of the neurospheres vs. differentiated cells
(748 genes). Again, the most noteworthy result is that
neurospheres of different passages (B-CI) have a surpris-
ingly high number of DE genes (383 genes) compared to
the other comparisons. To further explore the magnitude
of differential expression of these genes (with p < 0.001)
a table of their distribution over fold change was made
(Table 1). As expected, a high number of genes have high
fold changes for the passage and isolation replicates and
B-value distribution for each of the comparisons; The B-value  is calculated through empirical Bayes statistics and scores the  genes according to their probability of differential expression Figure 2
B-value distribution for each of the comparisons; The B-value 
is calculated through empirical Bayes statistics and scores the 
genes according to their probability of differential expression. 
Higher B-value means higher probability of differential 
expression. NS = neurosphere, DC = differentiated cells.BMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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Graphs displaying the variability of the data at different levels of replication; In all graphs one dot represents one gene Figure 3
Graphs displaying the variability of the data at different levels of replication; In all graphs one dot represents one gene. Panel A) 
shows MA-plots for each comparison. The x-axis represents the intensity of the feature (A = 1/2log2(Cy5*Cy3)). The y-axis 
represents the magnitude of differential expression of the gene (M = log2(Cy5/Cy3)), calculated after filtration and normalisa-
tion of the data. Dotted lines are drawn at M-values 1 and -1, i.e. at a 2-fold difference in signal intensity between the compared 
samples. Panel B) shows volcano plots for each sample. The x-axis shows the M-value for each gene and the y-axis the corre-
sponding B-value (calculated by empirical Bayes moderated t-test) for that gene. Panel C) shows scatter plots for each compar-
ison. The x-axis displays the average signal intensity for one sample and the y-axis the average signal intensity for the other 
sample. Also shown are the values of the Pearson correlation coefficient (r) and the coefficient of determination (R2).
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the neurosphere vs. differentiated cells comparison,
whereas fewer genes are within the higher fold change
ranges for the culture replicates.
To investigate whether the transcript level differences in
the two culture-to-culture comparisons are consistent or
random events a Venn diagram was created in Figure 5,
displaying the number of shared and unique DE genes in
the CI-CII, CII-CIII and F-G comparisons. Five genes out
of 27 (CI-CII) and 82 (CII-CIII) overlap, equivalent to
Table 1: Distribution of differentially expressed genes over fold change.
M interval Fold change A1-A2 CI-CII CII-CIII B-CI A2-CIII CII-F F-G
+/-(0–0.5) 0–1.4 17 16
+/-(0.5–1) 1.4–2 14 51 260 7 147 455
+/-(1–1.5) 2–2.8 12 26 108 20 14 190
+/-(1.5–2) 2.8–4 1 4 14 5 2 52
+/-(2–2.5) 4–5.6 1 1 19
+/-(>2.5) >5.6 11 6
Total p < 0.001 (fdr) 0 27 82 383 32 181 748
Genes with p < 0.001, calculated by empirical Bayes moderated t-test and false discovery rate adjustment, are included. (M = log2(Cy5/Cy3)).
The number of differentially expressed genes in each com- parison; Genes with p < 0.001, calculated by empirical Bayes  moderated t-test and false discovery rate adjustment, are  included Figure 4
The number of differentially expressed genes in each com-
parison; Genes with p < 0.001, calculated by empirical Bayes 
moderated t-test and false discovery rate adjustment, are 
included. NS = neurosphere, DC = differentiated cells.
Overlap of differentially expressed genes; Compared are the  results from the parallel cultures (CI-CII and CII-CIII) and the  neurosphere vs. differentiated cells comparison (F-G) Figure 5
Overlap of differentially expressed genes; Compared are the 
results from the parallel cultures (CI-CII and CII-CIII) and the 
neurosphere vs. differentiated cells comparison (F-G). Genes 
with p < 0.001, calculated by empirical Bayes moderated t-
test and false discovery rate adjustment, are included.BMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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19% and 6% respectively. The vast majority of DE genes
are thus not shared between the two comparisons, indi-
cating non-systematic changes in gene expression. When
compared to the neurosphere vs. differentiated cells gene
list only one of the five genes is in common, further dem-
onstrating random differences between cultures.
A list of the DE genes found in the neurosphere vs. differ-
entiated cells comparison (F-G) is provided as an addi-
tional data file 1: Differentially expressed genes in
neurosphere vs. differentiated cells comparison (the com-
plete results for all comparisons are available in ArrayEx-
press using experiment accession number E-MEXP-297).
The genes that show four-fold or greater fold change (M ≥
|2|) and adjusted p-values < 0.001 are shown in Table 2.
This demonstrates that genes found in the F-G compari-
son are genes that are expected to be involved in the dif-
ferentiation of neurospheres. For example, included are
several myelin related genes such as myelin-associated oli-
godendrocytic basic protein (Mobp),  myelin basic protein
(Mbp) and myelin-associated glycoprotein (Mag), all of
which are up-regulated in the differentiated sample. Also,
there are some genes related to transmitter substances and
their signaling; gamma-aminobutyric acid (GABA-A) recep-
tor, subunit beta 1 (Gabrb1)and guanine nucleotide binding
protein, alpha o (Gnao1), which is involved in dopamine
Table 2: 1Genes differentially expressed in the neurosphere vs. differentiated cells comparison (F-G).
Genbank Acc.no. Unigene ClusterID GeneID Gene Name M B
CX240827 Mm.200608 12759 Clusterin -3,503 22,292
CX241145 Mm.289645 17263 GTL2, imprinted maternally expressed untranslated mRNA -3,774 21,684
CX238761 Mm.354720 14681 Guanine nucleotide binding protein, alpha o -3,112 21,128
CX241318 Mm.289645 17263 GTL2, imprinted maternally expressed untranslated mRNA -4,429 18,116
CX235874 Mm.40461 17433 Myelin-associated oligodendrocytic basic protein -2,961 18,854
CX236810 Mm.210815 20411 Sorbin and SH3 domain containing 1 -2,287 17,999
CX241478 Mm.25874 77976 RIKEN cDNA B230104P22 gene -3,435 17,660
CX241468 Mm.4543 13390 Distal-less homeobox 1 -2,843 16,192
CX240901 Mm.271178 67166 ADP-ribosylation factor-like 10C -2,606 15,924
CX238347 Mm.252063 17196 Myelin basic protein -2,622 15,450
CX240173 Mm.291442 20692 Secreted acidic cysteine rich glycoprotein -2,008 14,973
CX240709 Mm.30035 107747 Formyltetrahydrofolate dehydrogenase 2,065 14,714
CX238313 Mm.206505 21858 Tissue inhibitor of metalloproteinase 2 -2,669 14,533
CX236462 Mm.34126 74617 Serine carboxypeptidase 1 -2,544 13,912
CX242347 Mm.271770 433496 Similar to Myl9 protein -2,860 13,549
CX243886 Mm.289645 17263 GTL2, imprinted maternally expressed untranslated mRNA -2,213 13,547
CX235484 Mm.178246 216848 Chromodomain helicase DNA binding protein 3 -2,313 12,737
CX241157 Mm.194225 70397 RIKEN cDNA 1110020A09 gene -2,045 12,600
CX243757 Mm.260601 242521 Kelch-like 9 (Drosophila) -2,848 12,607
CX237579 Mm.40461 17433 Myelin-associated oligodendrocytic basic protein -2,000 11,957
CX242456 Mm.291442 20692 Secreted acidic cysteine rich glycoprotein -2,835 11,842
CX238326 Mm.1426 51791 Regulator of G-protein signaling 14 -2,193 11,543
CX239776 Mm.252063 17196 Myelin basic protein -2,606 11,414
CX235557 Mm.241355 17136 Myelin-associated glycoprotein -2,220 11,257
CX239390 Mm.213204 80906 Kv channel-interacting protein 2 -2,126 10,915
CX239520 Mm.21549 80888 Heat shock 27 kDa protein 8 -2,104 10,657
CX238589 Mm.226704 14400 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 1 -2,039 10,744
CX242889 Mm.29358 67971 RIKEN cDNA 2700055K07 gene -2,032 10,827
CX235601 Mm.4857 12323 Calcium/calmodulin-dependent protein kinase II, beta 2,418 10,025
CX242440 Mm.121920 20660 Sortilin-related receptor, LDLR class A repeats-containing -2,180 8,923
CX240196 Mm.181959 13653 Early growth response 1 2,469 8,456
CX242602 #N/A -2,692 8,087
CX240394 Mm.18830 77569 RIKEN cDNA 3732412D22 gene -2,078 7,216
CX237453 Mm.181959 13653 Early growth response 1 2,059 6,141
CX244387 Mm.211275 76441 Dishevelled associated activator of morphogenesis 2 -2,347 4,185
CX236987 Mm.329668 20743 Spectrin beta 3 -2,014 2,723
Genes with p < 0.001, calculated by empirical Bayes moderated t-test and false discovery rate adjustment, and fold change ≥  4 (-2 ≥  M ≥  2), are 
included. Genes with M-value < 0 are up-regulated in differentiated cells, genes with M-value > 0 are up-regulated in neurospheres. M = log2(Cy5/
Cy3), B = B-value calculated by empirical Bayes moderated t-test. Higher B-values mean higher probability for differential expression. For a full list 
of differentially expressed genes in the F-G comparison see additional data file 1: Differentially expressed genes in neurosphere vs. differentiated 
cells comparison. BMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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signaling [18]. Distal-less homeobox 1 (Dlx1), is also widely
expressed in the brain and is involved in brain develop-
ment and neural differentiation [19-21].
To understand the biological significance of the overall
changes in gene expression, DE genes in the neurosphere
vs. differentiated cells comparison (F-G) were categorised
according to their gene ontology theme annotation.
Genes with an adjusted p < 0.001 were included in the
analysis and the probability of a theme being over-repre-
sented in the data was calculated using Jackknife Fisher's
exact probability test implemented in the EASE software
[22]. Table 3 shows the most highly represented gene
ontology themes (of category biological function).
Themes that showed enrichment in differentiated cells
include neurogenesis, synaptic transmission, cell-cell
signalling and development. In contrast, themes that
showed enrichment in neurospheres include electron
transport and mitotic cell cycle.
Discussion
This study has taken advantage of a recent template ampli-
fication method to study neurospheres at the level of tran-
scription. RNA from different isolations, cultures and
passages was isolated, amplified and analysed by microar-
rays. The comparison was performed by analysis of the
number of differentially expressed genes for the different
conditions. The results show excellent performance of the
amplification protocol. No differentially expressed genes
were found in the technical replicates indicating that
methodological noise in all comparisons should be con-
sidered minor.
Fluctuations of transcript levels in different populations of 
neurospheres
The array results for the different neurosphere conditions
were much more divergent than the technical replications
and we observe a varying degree of heterogeneity among
the different neurosphere populations, obtained from dif-
ferent isolations of adult mouse lateral ventricle wall tis-
sue, from different passages and from parallel cultures.
The results show that there is a large variation in gene
expression between neurospheres from different isola-
tions as well as between neurospheres from the same iso-
lation but from different passages. Neurospheres have
previously been shown to gain altered properties through
extensive, long-term passaging (more than 10 passages)
[23]. Short-term passaged neurospheres have been con-
sidered rather stable, with unaltered multipotency and
capacity for self-renewal [24]. Here we have shown that
already between passages one and two neurospheres show
altered gene expression with up to 383 DE genes (p <
0.001). Whether this is due to different properties of the
parental, clonally expanded cell(s) giving rise to the neu-
rospheres in each passage or some other reason needs to
be further investigated.
Parallel culturing of neurospheres from the same isolation
and the same number of passages, grown in identical con-
ditions, show fewer DE genes (up to 82 genes, p < 0.001)
Table 3: The most highly represented gene ontology themes in the neurosphere vs. differentiated cells comparison (F-G).
Biological process no of genes on array no of DE genes in F-G enriched in NS enriched in DC Fisher Exact
cell adhesion 56 17 6 (35%) 11 (65%) 0.00939
lipid metabolism 71 20 8 (40%) 12 (60%) 0.0123
neurogenesis 35 12 2 (17%) 10 (83%) 0.0101
mitotic cell cycle 30 10 7 (70%) 3 (30%) 0.0225
synaptic transmission 35 11 2 (18%) 9 (82%) 0.0266
development 166 37 8 (22%) 29 (78%) 0.0429
neuromuscular physiol. process 37 11 2 (18%) 9 (82%) 0.0396
transmission of nerve impulse 37 11 2 (18%) 9 (82%) 0.0396
electron transport 38 11 8 (73%) 3 (27%) 0.0476
endocytosis 24 8 2 (25%) 6 (75%) 0.0399
organismal movement 43 12 3 (25%) 9 (75%) 0.0511
siderochrome transport 34 10 4 (40%) 6 (60%) 0.0522
alcohol metabolism 39 11 4 (36%) 7 (64%) 0.0565
neurophysiological process 49 13 3 (23%) 10 (77%) 0.0626
organismal physiological process 86 20 5 (25%) 15 (75%) 0.0842
energy pathways 36 10 7 (70%) 3 (30%) 0.0739
cell-cell signaling 41 11 2 (18%) 9 (82%) 0.0777
Organogenesis 89 20 4 (20%) 16 (80%) 0.112
Analysis is restricted to themes of category biological function. Genes with p < 0.001, calculated by empirical Bayes moderated t-test and false 
discovery rate adjustment were included in the analysis. Shown is the total number of genes found in the respective theme, as well as the number of 
those genes that are enriched in neurospheres (NS) and differentiated cells (DC) respectively. Jackknife Fisher's exact probability test was used to 
identify over-represented themes in the data. Corresponding p-values are listed. BMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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than neurospheres compared between passages (383
genes, p < 0.001). Furthermore, when neurospheres are
induced to differentiate and compared to undifferentiated
neurospheres cultured in parallel, the number of genes DE
as well as the magnitude of the M-values are clearly higher
(748 genes, p < 0.001). These data indicate that an
extended 3–4 day culturing, per se, is sufficient to induce
changes in gene expression, but with careful experimental
design and an appropriate number of biological replicates
neurospheres cultured in parallel, from the same isolation
and passage, may be used to study for example the effect
of exposure to different microenvironments on gene
expression.
The gene expression heterogeneity of neurospheres may
be related to a number of different factors such as the age
of the animal from which they were isolated, neurosphere
size and the identity of the first clonally expanded cell
[25]. Our results are also confirmed by observations by
Suslov and co-workers that examined the expression of 16
transcripts from single neurospheres of different sizes [8].
The obtained information was used to cluster the
individual neurospheres according to similar gene expres-
sion pattern. It revealed an inter-clonal heterogeneity that
might reflect the maturity and developmental commit-
ment of the parental clonogenic cell, as well as the size of
the neurosphere and its time in culture. In another study
it was shown that populations of neurospheres from dif-
ferent regions of the brain as well as from different species
differ in properties such as growth rate, neuronal produc-
tion and cell morphology [26].
Genes expressed in neurospheres
The different neurosphere populations show heterogene-
ity in their expression profiles, yet many of the genes
expressed are representative of a neurosphere transcript
signature. As described earlier, neurospheres consist of
several cell types of varying degrees of differentiation, a
dense extracellular matrix and extensive cell-cell contacts.
Electron-microscopy studies of rat fetal striatum EGF-
expanded neurospheres [27], have shown that they con-
sist of two types of cells, electron-dense and electron-
lucent cells, both of which could be either healthy, apop-
totic or necrotic. These neurosphere cells also
demonstrated an expression of the cell adhesion mole-
cules E- and N-cadherin (Cdh1 and Cdh2), α - and β -cat-
enin (Catna1, LOC297357 and RGD:70487) and growth
factor receptors for epidermal growth factor (Egfr) and
fibroblast growth factor (Fgfr1), as well as fibroblast growth
factor 2 (Fgf2). Also neurospheres from adult human
brain have been characterised, revealing the same type of
heterogeneous, complex structure [28,7]. These express a
variety of different markers, such as nestin (NES; neural
stem/progenitor and immature glial marker), vimentin
(VIM; immature glia), glial fibrillary acidic protein (GFAP;
astrocytes), β -III-tubulin (TUBB3; neuronal marker) and
cell adhesion molecule L1 (L1CAM; neuronal marker), prote-
olipid protein 1 (PLP1; oligodendrocytes), B-cell CLL/lym-
phoma 2 (BCL2; anti-apoptotic), paired box gene 6 (PAX6;
a developmentally regulated gene) and tenascin C (TNC;
extracellular matrix protein). In our study the genes
related to these phenotypes and markers are expressed at
similar levels in all neurosphere replicates (CI-CII, CII-
CIII, B-CI, A2-CIII and CII-F). For example we observe
many genes involved in apoptosis; Bcl2-associated X protein
(Bax), Bcl2-associated athanogene 1 (Bag1), cytochrome c-1
(Cyc1), death associated protein 3 (Dap3), programmed cell
death 6 interacting protein (Pdcd6ip) and phosphoprotein
enriched in astrocytes 15 (Pea15). Expressed are also α -E-
catenin (Catna1), β -catenin (Catnb) and fibroblast growth
factor 3 (Fgfr3), and other neurosphere markers such as
nestin (Nes), glial fibrillary acidic protein (Gfap), β -III-tubu-
lin (Tubb3) and proteolipid protein 1 (Plp1) (The complete
data set is available in ArrayExpress using experiment
accession number E-MEXP-297).
The list of DE genes in the neurosphere vs. differentiated
cells comparison (Table 2 and additional data file 1: Dif-
ferentially expressed genes in neurosphere vs. differenti-
ated cells comparison) as well as an overview of the
corresponding gene ontology classification (Table 3) also
demonstrates the anticipated differences between neuro-
spheres and differentiated neurospheres.
Summary
The genes observed to be differentially expressed in iden-
tical but parallel cultures appear to be random, shown by
the low overlap in DE genes between the two parallel cul-
ture comparisons (Figure 5). The number of erroneously
identified DE genes, due to biological fluctuations, could
hence be lowered by increasing the number of biological
replicates. Hereby random differences will be removed
and true DE genes can be selected by statistical means. It
should be noted that the random differences mainly cor-
respond to small fold changes as compared to the larger
changes in the neurospheres vs. differentiated cells. Relia-
ble differences in gene expression could therefore be
obtained and studied without increasing the number of
replicates if a higher cut-off for DE genes, such as fold
change > 2, was chosen.
Conclusions
We have shown that the tag cDNA amplification method
is well suited for the analysis of neurospheres, demon-
strating low technical variability. Furthermore we have
demonstrated large differences between passages of neu-
rospheres, but less variability between parallel cultures.
The described variability appears to be random and the
underlying cause(s) needs further investigations. The neu-
rosphere variability can be addressed by increasing theBMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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number of biological replicates and careful experimental
design, which will facilitate future use of neurospheres as
a tool to study gene expression changes involved in
neurogenesis.
Methods
Adult mouse neural stem cell culture
Three adult mouse neural stem cell cultures were initiated,
the first originating from tissue isolated from ten mice
(Culture 1) while the second (Culture 2) and third (Cul-
ture 3) cultures originated from three mice each. For each
culture, identical dissection, dissociation and culture pro-
tocols were used. Briefly, the lateral wall of the lateral ven-
tricle of 5–6-week-old mice was enzymatically dissociated
in 0.8 mg/ml hyaluronidase and 0.5 mg/ml trypsin in
Dulbecco's modified Eagle medium (DMEM) containing
4.5 mg/ml glucose and 80 U/ml DNase at 37°C for 20
min. The cells were gently triturated and mixed with three
volumes of neurosphere medium (DMEM/F12, B27 sup-
plement, 12.5 mM HEPES pH7.4) containing 20 ng/ml
EGF, 100 U/ml penicillin and 100 µg/ml streptomycin.
After passing through a 70-µm strainer, the cells were
pelleted at 160 × g for 5 min. The supernatant was subse-
quently removed and the cells resuspended in neuro-
sphere medium supplemented as above, plated in
uncoated culture dishes and incubated at 37°C. Neuro-
spheres were ready to be split 7–8 days after plating.
To split neurosphere cultures, neurospheres were col-
lected by centrifugation at 160 × g for 5 min. The neuro-
spheres were resuspended in 0.5 ml Trypsin/EDTA in
HBSS (1x), incubated at 37°C for 2 min and triturated
gently to aid dissociation. Following a further three-min
incubation at 37°C and trituration, 3 volumes of ice-cold
neurosphere medium containing EGF were added. The
cells were pelleted at 220 × g for 4 min, resuspended in
fresh neurosphere medium supplemented with 20 ng/ml
EGF.
From Cultures 1, 2 & 3, dissociated cells were plated and
grown in neurosphere medium supplemented with EGF
for a further 3–4 days by which time secondary neuro-
spheres had developed. The secondary neuropheres
originating from Culture 1 were harvested for mRNA iso-
lation (Sample A). Approximately a quarter of the second-
ary neurospheres originating from Culture 2 were also
taken for mRNA isolation (Sample B), while the remain-
der were dissociated and replated in three equal fractions
(100,000 cells / well (6 well plate)), cultured in neuro-
sphere medium supplemented with EGF for 3 days, and
harvested for mRNA isolation (Samples CI, CII, CIII). Sec-
ondary neurospheres originating from Culture 3 were dis-
sociated and divided into two fractions. The first fraction
was replated (100,000 cells / well (6 well plate)) and
cultured identically to the cells generating Samples CI, CII
& CIII. After 3 days, the cells were harvested for mRNA iso-
lation (Sample F). The second fraction was replated in
neurosphere medium supplemented with 1% fetal calf
serum (FCS) onto poly-D-lysine plates to which the cells
adhered. After incubating, overnight FCS concentration
was reduced to 0.5%, and the cells cultured a further 2
days before centrifugation and subsequent mRNA isola-
tion (Sample G, differentiated cells). All experiments were
approved by the Karolinska Institute Ethical Committee.
cDNA synthesis
Messenger RNA was isolated using Dynabeads® mRNA
DIRECT™ Kit from Dynal (Dynal A.S., Norway), according
to the manufacturer's instructions. First- and RNaseH
dependent second-strand cDNA synthesis (SuperScript
Choice System for cDNA Synthesis) was performed
according to the manufacturer's instructions (Invitrogen,
CA, USA) using 45 pmol biotinylated NotI-oligo(dT)
primer (5'-biotin-GAGGTGCCAACCGCGGCCGC (T)15-
3'). The cDNA was phenol-chloroform extracted and
ethanol precipitated and the pellet was dissolved in 40 µl
of 1 × TE (10 mM Tris-HCl, 1 mM EDTA). Excess NotI-
oligo(dT) primer was removed by Chromaspinn TE-100
column (Clontech, CA, USA).
Amplification of 3'-end signature tags
The cDNA was fragmented and amplified according to a
protocol previously described [3,4]. Shortly, fragmenta-
tion of the cDNA was performed in 40 µl 1 × TE using an
inverted sonication probe, using 16 × 10 sec pulses at 90%
effect (Sonifier® B-12, Branson Sonic Power Company, CT,
USA). Biotinylated 3'-end signature tags from the frag-
mented cDNA population were isolated onto 20 µl of par-
amagnetic streptavidin-coated beads (10 mg/ml) (Dynal
A.S.) in 40 µl sample plus 40 µl Binding/Washing buffer
(2 M NaCl, 0.1% Tween 20 in 1 × TE, pH 7.7) at 37°C for
one hour with rotation. The immobilised signature tags
were end repaired using 1.5 U T4 DNA polymerase (New
England BioLabs, MA, USA) in a 30-µl reaction volume at
12°C for 20 minutes according to the supplier's recom-
mendations. Blunt-end adapters (Sima18: 5'-GGATC-
CGCGGTG-3'; Sima19: 5'-
TCTCCAGCCTCTCACCGCGGATCC-3') were pre-
annealed and ligated onto the immobilised repaired 3'-
end signature tags using a solution comprising 1.1 nmol
adapter, ligase buffer (66 mM Tris-HCl, pH 7.6, 5 mM
MgCl2, 5 mM DTT, 50 µg/ml BSA), 0.2 mM ATP, 1200 U
T4 DNA ligase (New England BioLabs) in a final volume
of 60 µl. Ligation was performed overnight at room tem-
perature with constant rotation to keep beads in suspen-
sion. The signature tags were released from the magnetic
beads by restriction with NotI (New England BioLabs) for
2 hours in a volume of 60 µl while keeping the beads in
suspension. Five micro litres of the eluate containing the
3'-end signature tags was used as template in a subsequentBMC Neuroscience 2005, 6:28 http://www.biomedcentral.com/1471-2202/6/28
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PCR. The PCR was performed in 100 µl containing 200
µM of each dNTP, 0.75 µM Sima19, 0.75 µM  NotI-
oligo(dT) primer, 65 mM Tris-HCl pH 8.8, 4 mM MgCl2,
16 mM (NH4)2SO4, 0.5 µM BSA and 3 U AmpliTaq DNA
polymerase (Perkin Elmer, MA, USA). Cycling was
performed according to the following procedure, initial
incubation at 72°C for 3 min, followed by addition of Taq
DNA polymerase and subsequent cycling: 72°C for 20
min, 95°C for 1 min, 45°C for 5 min, 72°C for 15 min,
followed by four cycles (95°C for 1 min, 50°C for 1 min,
72°C for 15 min), and 13 cycles (as previously optimised)
(95°C for 1 min, 50°C for 1 min, 72°C for 2 min).
Target labelling and microarray hybridisation
The 3'-end signature tags were purified using QIAquick®
PCR purification kit (Qiagen, Germany). Direct labelling
was performed using Cy3-dCTP or Cy5-dCTP (Perkin
Elmer, MA, USA) in a linear, asymmetric PCR. The reac-
tion was performed in a 50-µl labelling mix containing
100–200 ng purified 3'-end signature tags, 80 µM dATP,
dGTP and dTTP, 20 µM dCTP, 5 µM Sima19 primer, 2 mM
MgCl2, 1 × PCR Buffer II (Applied Biosystems, Ca, USA),
3 U AmpliTaq Gold® (Applied Biosystems) and 60 pM
Cy3-dCTP or Cy5-dCTP. The labelling mix was cycled as
follows: 95°C for 12 min, then 20 cycles (95°C for 30 sec,
50°C for 30 sec, 72°C for 10 min). Excess primer and
nucleotides were removed using QIAquick® PCR purifica-
tion kit (Qiagen). The eluted labelling products were
speed vacuumed until dry, then dissolved in 55 µl hybrid-
isation buffer (24% formamide, 5 × SSC and 0.1% SDS)
(20 × SSC contains 3 M NaCl and 0.3 M Na3citrate ×
2H2O). Cy3 and Cy5 labellings were blended and mixed
with 25 µg human Cot-1 DNA (Invitrogen) and 50 µg
polyA DNA (Operon Biotechnologies GmbH, Germany).
The arrays (ArrayExpress accession number E-MEXP-297,
submission in progress) [29] contained 5169 probes
originating from a lateral ventricle wall cDNA library
(clone library "Mus Musculus Lateral Ventricle Wall
C57BL/6 adult") and a set of control features all printed in
duplicate. Details regaring the array manufacturing are
available through ArrayExpress. Briefly, probes were gen-
erated through PCR amplification and subsequently puri-
fied using Multiscreen-384 filter plates (Millipore).
Purified products in 50% DMSO were printed onto GAPS-
II slides (Corning Inc) using the QArray arrayer (Genetix)
and attached using 250 mJ UV-light (Stratalinker). The
arrays were first prehybridised for 30 min in a 42°C pre-
hybridisation solution (1% BSA, 5 × SSC, 0.1% SDS), then
washed in water and isopropanol and dried through cen-
trifugation. The sample was denatured in 95°C for 3 min,
then applied to the array and incubated in a hybridisation
chamber in 42°C for 18 hours. After hybridisation the
arrays were washed in three successive wash buffers with
increasing stringency: (1) 1 × SSC and 0.2% SDS, 42°C,
(2) 0.1 × SSC and 0.2% SDS, room temperature, (3) 0.1 ×
SSC, room temperature. All wash steps were made on a
shaking table for 4 min. After the last step the array was
immediately centrifuged in a slide centrifuge and kept in
the dark until scanning. Scanning was performed using
the GMS 418 Array Scanner from Genetic MicroSystems
(Affymetrix Inc, CA, USA).
Image and data analysis
All image and data analysis steps were conducted in Gene-
Pix Pro 4.1.1.4 (Axon Instruments Inc, CA, USA) or R [30].
The analysis in R was carried out using Bioconductor [31],
LIMMA [16], aroma [32] and the kth-package [33]. The
analysis was conducted according to the following
workflow. (1) Image tiff-files were created by scanning the
microarrays with the GMS 418 Array Scanner. (2) Feature
identity and foreground/background intensities were
extracted from the tiff files using GenePix Pro 4.1.1.4. (3)
GenePix result files were imported into R and gene expres-
sion measurements were obtained for each feature by sub-
tracting the median of the local background from the
median of the foreground signal. (4) A filter was used to
identify and correct for features that had one channel
(Cy3 or Cy5) below the background or at zero and one
channel stronger than the background. The signal in the
weaker channel was for these spots set to one plus the
intensity of the local background. Features with both
channels below the background or at zero were removed
from the data set. (5) A second filter was used to remove
features that were saturated in both channels. (6) A third
filter was used to remove features with abnormal size
(below 110 and above 230 µm in diameter). (7) A fourth
filter was used to remove features where both signals had
more than 70% of the pixels in the feature below the local
background signal plus two standard deviations. (8) The
last filter was used to remove features that were flagged as
not found by GenePix. (9) Filtered data was normalised
separately for each individual block on the slide using a
robust local regression, print-tip lowess normalisation
[34]. (10) An empirical Bayes moderated t-test [15-17]
was used to rank the genes according to evidence of differ-
ential expression. The obtained p-values were adjusted for
multiple testing using the false discovery rate adjustment
[35] implemented in R. A p-value of less than 0.001 was
considered significant and the associated gene termed dif-
ferentially expressed (DE). The experimental design
included reciprocal dye label assignments. These were
swapped prior to the moderated t-test so that in each com-
parison the genes in the sample with an abbreviation that
comes earlier in alphabetical order (e.g. B in B vs. CI) have
positive M-values if they have a higher expression level.
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